Home » Topics » Regulatory » Patents

Patents
RSS

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Carbapenem derivatives with antibacterial activity claimed by Yamanouchi

July 26, 1996

Human Genome Sciences claims VIGF polypeptide technology

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...